VIGIL NEUROSCIENCE, INC. Financing Cash Flow
VIGIL NEUROSCIENCE, INC. reported Financing Cash Flow of $13.54 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-08-05
- VIGIL NEUROSCIENCE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $273.00K, a 2933.33% increase year-over-year.
- VIGIL NEUROSCIENCE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $13.27M, a 155.92% increase year-over-year.
- VIGIL NEUROSCIENCE, INC. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $4.44M, a 8269.81% increase year-over-year.
- VIGIL NEUROSCIENCE, INC. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $19.86M, a 37373.58% increase year-over-year.
- VIGIL NEUROSCIENCE, INC. net cash provided by (used in) financing activities for fiscal 2024 was $29.49M, a 3220.95% increase from fiscal 2023.
- VIGIL NEUROSCIENCE, INC. net cash provided by (used in) financing activities for fiscal 2023 was $888.00K, a 99.45% decline from fiscal 2022.
- VIGIL NEUROSCIENCE, INC. net cash provided by (used in) financing activities for fiscal 2022 was $161.25M, a 49.66% increase from fiscal 2021.
- VIGIL NEUROSCIENCE, INC. net cash provided by (used in) financing activities for fiscal 2021 was $107.75M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $13.54M 10-Q · filed 2025-08-05 | $17.98M derived: sum of 3 quarters · filed 2025-08-05 | $37.84M derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | $13.27M 10-Q · filed 2025-05-07 | $17.70M derived: sum of 2 quarters · filed 2025-05-07 | $37.56M derived: sum of 3 quarters · filed 2025-05-07 | $37.57M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-12-31 | $4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $24.30M derived: sum of 2 quarters · filed 2025-03-13 | $24.31M derived: sum of 3 quarters · filed 2025-08-05 | $29.49M 10-K · filed 2025-03-13 |
| 2024-09-30 | $19.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $19.87M derived: sum of 2 quarters · filed 2025-08-05 | $25.05M 10-Q · filed 2024-11-07 | $25.11M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $5.19M 10-Q · filed 2025-08-05 | $5.25M derived: sum of 3 quarters · filed 2025-08-05 | $5.30M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $5.18M 10-Q · filed 2025-05-07 | $5.24M derived: sum of 2 quarters · filed 2025-05-07 | $5.29M derived: sum of 3 quarters · filed 2025-05-07 | $5.87M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $106.00K derived: sum of 2 quarters · filed 2025-03-13 | $685.00K derived: sum of 3 quarters · filed 2025-03-13 | $888.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $632.00K derived: sum of 2 quarters · filed 2024-11-07 | $835.00K 10-Q · filed 2024-11-07 | $936.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $579.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $782.00K 10-Q · filed 2024-08-13 | $883.00K derived: sum of 3 quarters · filed 2024-08-13 | $72.17M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $203.00K 10-Q · filed 2024-05-07 | $304.00K derived: sum of 2 quarters · filed 2024-05-07 | $71.60M derived: sum of 3 quarters · filed 2024-05-07 | $71.27M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $71.39M derived: sum of 2 quarters · filed 2024-03-26 | $71.06M derived: sum of 3 quarters · filed 2024-03-26 | $161.25M 10-K · filed 2024-03-26 |
| 2022-09-30 | $71.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $70.96M derived: sum of 2 quarters · filed 2023-11-07 | $161.15M 10-Q · filed 2023-11-07 | $159.29M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $89.86M 10-Q · filed 2023-08-08 | $88.00M derived: sum of 3 quarters · filed 2023-08-08 | $177.70M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $90.19M 10-Q · filed 2023-05-10 | $88.33M derived: sum of 2 quarters · filed 2023-05-10 | $178.03M derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $87.84M derived: sum of 2 quarters · filed 2023-03-21 | $107.75M 10-K · filed 2023-03-21 | |
| 2021-09-30 | $89.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $109.61M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $19.91M 10-Q · filed 2022-08-08 |